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Abstract 
For patients with head and neck cancer whose tumors are HPV negative HPV(-), current therapy 
does not lead to significant longevity and most succumb to loco-regional recurrence of the primary 
tumor. We discovered that HPV(-) head and neck squamous cell carcinoma (HNSCC) highly 
expressed ATPase family AAA-domain containing protein 3A (ATAD3A). ATAD3A is the 
mitochondrial protein, which has been demonstrated as an oncogene in breast and lung cancer. 
However, nothing has been reported regarding its role in HNSCC. Using the HPV(-) HNSCC cell 
line HN12 as a cell model, we show here that knockout of ATAD3A expression by CRISPY-CAS9 
in HNSCC cells, leading to reduced cell proliferation and decreased the ability of colony formation 
and anchorage-independent growth in soft agar. Importantly, ATAD3A loss also significantly 
suppressed HNSCC cells to grow in 3D culture. Together, these findings suggest the potential 
oncogenic role of ATAD3A in HNSCC cells, and implicate that ATAD3A represents a promising 
target for better treatment of patients with HPV(-) HNSCC. 
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